公司新闻 - 亚科因（Abbkine）—服务于细胞和蛋白研究全球用户

首页
技术中心
产品文献

或

货号	产品名称	文献标题	IF	杂志名称
A25012	IPKine山羊抗小鼠IgG轻链二抗，HRP标记 (规避重链干扰)	C-Jun/C7ORF41/NF-κB axis mediates hepatic inflammation and lipid accumulation in NAFLD	4	Biochemical Journal
A25012	IPKine山羊抗小鼠IgG轻链二抗，HRP标记 (规避重链干扰)	Disruption of Ssp411 causes impaired sperm head formation and male sterility in mice	4	Biochimica et Biophysica Acta (BBA) - General Subjects
A25012	IPKine山羊抗小鼠IgG轻链二抗，HRP标记 (规避重链干扰)	Caspase-8 drove apoptosis of BMECs to promote neutrophil infiltration and DE205B clearance in meningitis.	6.900	Microbiological Research
A25012	IPKine山羊抗小鼠IgG轻链二抗，HRP标记 (规避重链干扰)	Nuclear localization signal in TRIM22 is essential for inhibition of type 2 porcine reproductive and respiratory syndrome virus replication in MARC-145 cells	2	Virus Genes, October 2019, Volume 55, Issue 5, pp 660–672
A25012	IPKine山羊抗小鼠IgG轻链二抗，HRP标记 (规避重链干扰)	Transcriptomic analysis reveals potential novel circRNA in goiters progression.	4	Gene
A25012	IPKine山羊抗小鼠IgG轻链二抗，HRP标记 (规避重链干扰)	Immune evasion strategy involving propionylation by the KSHV interferon regulatory factor 1 (vIRF1)	7	PLoS Pathogens
A25012	IPKine山羊抗小鼠IgG轻链二抗，HRP标记 (规避重链干扰)	NEK2 induces autophagy‐mediated bortezomib resistance by stabilizing Beclin‐1 in multiple myeloma	6	Molecular Oncology
A25012	IPKine山羊抗小鼠IgG轻链二抗，HRP标记 (规避重链干扰)	Mitochondrial dysfunction induces NLRP3 inflammasome activation during cerebral ischemia/reperfusion injury	6	Journal of Neuroinflammation
A25012	IPKine山羊抗小鼠IgG轻链二抗，HRP标记 (规避重链干扰)	Exosomes derived from bone marrow mesenchymal stem cells protect the injured spinal cord by inhibiting pericyte pyroptosis	3	Neural Regen Res
A25012	IPKine山羊抗小鼠IgG轻链二抗，HRP标记 (规避重链干扰)	hnRNPA2B1 represses the disassembly of arsenite-induced stress granules and is essential for male fertility	9	Cell Reports

首页上一页 257 258 259 260 261 262 下一页尾页

赋能细胞研究与治疗 Enabling cell research and therapy

联系我们

全国服务热线： 400-6800-830

订购邮箱： service@abbkine.com

联系地址：武汉光谷生物医药加速器17号楼1号房2-3层

友情链接：

Copyright ©Abbkine Scientific Co., Ltd- 鄂ICP备10204150号-5

意见反馈

 在线咨询

扫码关注

微信公众号

返回顶部